Marc David Benathen - 27 Jan 2023 Form 4 Insider Report for LifeMD, Inc. (LFMD)

Signature
/s/ Marc David Benathen
Issuer symbol
LFMD
Transactions as of
27 Jan 2023
Net transactions value
$0
Form type
4
Filing time
13 Jul 2023, 12:02:29 UTC
Previous filing
28 Jan 2022
Next filing
25 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFMD Common Stock Options Exercise $0 +25,000 +48% $0.000000 77,554 27 Jan 2023 Direct
transaction LFMD Common Stock Award +125,000 +161% 202,554 11 Jul 2023 Direct F1
transaction LFMD Common Stock Options Exercise $0 +25,000 +12% $0.000000 227,554 11 Jul 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LFMD Employee Stock Option (Right to Buy) Disposed to Issuer -200,000 -100% 0 11 Jul 2023 Common Stock 200,000 $21.20 Direct F1
transaction LFMD Restricted Stock Options Exercise $0 -25,000 -50% $0.000000 25,000 27 Jan 2023 Common Stock 25,000 Direct F2, F3
transaction LFMD Restricted Stock Options Exercise $0 -25,000 -100% $0.000000* 0 11 Jul 2023 Common Stock 25,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options are being cancelled in exchange for 125,000 restricted shares, with 50,000 vesting on January 1, 2024 and 75,0000 vesting on January 1, 2025, and performance shares to be reported on settlement. In addition, vesting accelerated immediately on 25,000 restricted stock previously granted to Mr. Benathen on January 27, 2022. The option vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following February 4, 2021.
F2 Restricted stock converts into common stock on a one-for-one basis.
F3 Restricted stock vested on January 27, 2023.